PPT-Advances in the Treatment of Iron Deficiency Anemia and Related Disorders in CKD

Author : conchita-marotz | Published Date : 2018-03-20

Program Goals Hepcidin in Chronic Kidney Disease Treatment of Iron Deficiency Anemia Assessment of IV Iron in Patients With NonDialysisDependent CKD DOPPS Study

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document "Advances in the Treatment of Iron Defici..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

Advances in the Treatment of Iron Deficiency Anemia and Related Disorders in CKD: Transcript


Program Goals Hepcidin in Chronic Kidney Disease Treatment of Iron Deficiency Anemia Assessment of IV Iron in Patients With NonDialysisDependent CKD DOPPS Study Ferric Pyrophosphate Phosphate Binders. Greg . Radin. 7/9/2013. Anemia. Definition:. Insufficient erythrocytes to carry O2 to peripheral tissues. Symptoms:. Tachycardia, DOE, decreased exercise . tol. , . pallor. . depend on severity and acuity.   . Seventh International Symposium in Continuing Nursing Education/March, 2014. 3/2014. Donald W. McLaren, MD. Objectives. To discuss how to evaluate and determine cause of anemia. To discuss Iron deficiency (ID) and Iron Deficiency Anemia (IDA) - causes, evaluation, signs, symptoms, treatment and prevention at different ages. O+G Update 2014. Hospital . Sarikei. What is Anemia. Disorder by which the body is depleted of RBC to carry adequate oxygen to tissues. NICE Guidelines (for pregnant woman). Hb. level <10.5g/dl throughout pregnancy. Rafi Ahmed, MD. Hematology and Oncology Fellow. 4-10-14. Overview. Not a diagnosis, but a sign of disease. Warrants an investigation. Definition: Reduction in oxygen carrying capacity of blood due to decreased erythrocyte mass. Mohammad Asgar Khan, MD. Anemia. Learning Objectives:. Learn the pathophysiology of anemia in CKD.. Learn the diagnostic challenges of anemia in CKD.. Learn the therapeutic strategies and related controversies in the treatment of anemia in CKD.. Be able to classify the different types of anemia. Understand the signs and symptoms associated with anemia.. Being able to interpret lab abnormalities to diagnose different causes of anemia. . Introduction to Anemia. Assistant Professor of Medicine & Oncology, Division of Hematology. Disclosures. None. Objectives. Understand the basic physiology of iron absorption, transport and storage. Understand the causes of iron deficiency and the compensatory responses seen in clinical lab tests. Be able to classify the different types of anemia. Understand the signs and symptoms associated with anemia.. Being able to interpret lab abnormalities to diagnose different causes of anemia. . Introduction to Anemia. CKD . Patients. 2012 KDIGO . Update. Dr. . Shahram. . Taheri. . CKD is a worldwide public health issue. . The incidence and prevalence of kidney failure are increasing, outcomes are poor, and the cost is high. . IRON OVERLOAD. IRON. 10-15 mg/day in diet; 5-10% absorbed. Absorption increased in iron deficiency, pregnancy, erythroid hyperplasia, hypoxia. Heme iron absorbed best. Fe. 2 . much better than Fe. 3 . By Dr. Zahoor. 1. Anemia. What is Anemia?. . Anemia is present when there is decrease in hemoglobin (Hb) in the blood below the reference level for the age and sex . 2. 3. Normal Values for Peripheral Blood. Peri. -partum period in Iran . . Dr. . Sedigheh. . Hantoushzadeh. , Prof of . Perinatalogy. (Tehran University of Medical sciences). Globally, there is a high prevalence of . anemia. 3. 1. . Kassebaum. Swarnakshi. . Upadhyay. Assistant Professor. School of Pharmaceutical Sciences, CSJM University. DEFINITION. Anemia.  occurs when you have a decreased level of . hemoglobin. in your red blood cells (RBCs). . Carboxymaltose. J. . . Parissis. Heart Failure Unit,. Attikon. University Hospital, . Athens, Greece. Disclosures. Grants: ALARM investigator received research grants by Abbott US and Orion . Pharma.

Download Document

Here is the link to download the presentation.
"Advances in the Treatment of Iron Deficiency Anemia and Related Disorders in CKD"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.

Related Documents